Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2015-01-16
Original market date: See footnote 1
2015-01-16
Product name:
TEVA-FROVATRIPTAN
DIN:
02415844
Product Monograph/Veterinary Labelling:
Date:
2023-05-03
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ENDO PHARMACEUTICALS INC.
1400 Atwater Drive
Malvern
Pennsylvania
United States
19355
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
28:32.28
Anatomical Therapeutic Chemical (ATC): See footnote 4
N02CC07 FROVATRIPTAN
Active ingredient group (AIG) number:See footnote5
0150262001
| Active ingredient(s) | Strength |
|---|---|
| FROVATRIPTAN (FROVATRIPTAN SUCCINATE) | 2.5 MG |